China (Mainland)
- Product Details
Keywords
- antinéoplasique cytostatique
- Tumeurs cérébrales primitives ou secondaires
- cecenu
Quick Details
- ProName: Belustine;
- CasNo: 13010-47-4
- Molecular Formula: C9H16CIN3O2
- Appearance: yellow powder or yellow crystalline po...
- Application: Lomustine is a nitrosourea alkylator t...
- DeliveryTime: Delivery Lead Time ,7 days for ready g...
- PackAge: lastic bucket，25kg/package，200KG/packa...
- Port: any port in China
- ProductionCapacity: Metric Ton/Day
- Purity: ≥98%
- Storage: store in cool and dry place. Keep away...
- Transportation: By vessel, air or land
- LimitNum: 1 Kilogram
- Melting Point: 88-90 oC
- Solubility: Soluble in ethanol or chloroform or ac...
Superiority
CCNU is the trade name for lomustine. CeeNU is another name for lomustine.
In some cases, health care professionals may use the trade name CCNU or other
names CeeNu when referring to the generic drug name lomustine.
Lomustine is an anti-cancer ("antineoplastic" or "cytotoxic") chemotherapy drug. This
medication is classified as an "alkylating agent."
The application of Lomustine
· Treatment of brain tumors, both primary (developed in the brain) and metastatic (spread from another source).
· Hodgkin's disease and non-Hodgkin's lymphoma.
· Also has been used in treatment of melanoma, lung and colon cancer
Details
|
Formula |
C9H16CIN3O2 |
|
Molecular weight |
233.70 |
|
EINECS |
235-859-2 |
|
CAS RN |
13010-47-4 |
|
CAS Name |
|
|
Synonyms: |
1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea; (chloro-2-ethyl)-1-cyclohexyl-3-nitrosourea; (cloro-2-etil)-1-cicloesil-3-nitrosourea; 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosoure; 1-(2-chloroethyl)-3-cyclohexyl-1-nitroso-ure; belustine; cecenu; ceenu; chloroethylcyclohexylnitrosourea; cinu; cyclohexylchloroethylnitrosourea; icig1109; n-(2-chloroethyl)-n’-cyclohexyl-n-nitroso-ure; nci-c04740; nsc79037; nsc-79037; rb1509; 1-chloro-3-cyclohexyl-1-ethyl-3-nitrosourea |
|
Minimum assay |
≥98% |
|
Minimum stability |
|
|
Form |
yellow powder |
|
Solubility |
Soluble in ethanol (47 mg/ml at 25 °C), chloroform, water (<1 mg/ml at 25 °C), DMSO (47 mg/ml at 25 °C), and acetone. |
|
Application |
|
|
Usage |
a highly lipid soluble drug, treating brain tumors |
|
Melting point ca. |
88-90 ºC |
|
Boiling point ca. |
354.07 °C |
|
Density g/cm3 (20°C) |
1.31g/cm3 |
|
Refractive index |
1.57 |
|
Flash point |
133.2°C |
|
Stability |
Stable under recommended storage conditions |
|
Percent Composition |
C 46.25%, H 6.90%, Cl 15.17%, N 17.98%, O 13.69% |
|
Packaging |
required by customer |
|
Delivery Time |
overnight (USA/Canada); 3-5 days (worldwide) |
|
Storage |
Store at 4° C |
|
Transport information |
|
Plusieurs indications ont été retenues (proches de celles de la carmustine) , souvent en association :
Tumeurs cérébrales primitives ou secondaires,
Myélome multiple,
Lymphomes hodgkiniens ou non hodgkiniens,
Mélanomes.